Sign up
Pharma Capital

Trevor Hoey

Senior Journalist

Trevor enjoyed a long career with Fairfax Business Media writing on Australian equities for the AFR among other titles.


© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.